Abstract
Head and neck squamous cell carcinoma (HNSCC) is a leading cause of cancer-related death worldwide. Despite aggressive treatment approaches, the recurrence of HNSCC remains a challenge. Cytokines play an essential role in HNSCC development and progression. They are not only involved in promoting cancer growth but may also be involved in an anti-tumor immune response. Non-coding RNAs (ncRNAs) have emerged as important transcriptional and post-transcriptional mediators of cytokine function in HNSCC. This review focuses on the complex regulatory network among regulatory ncRNAs and cytokines during HNSCC pathogenesis.
Similar content being viewed by others
Abbreviations
- HNSCC:
-
Head and neck squamous cell carcinoma
- OSCC:
-
Oral squamous cell carcinoma
- NPC:
-
Nasopharyngeal carcinoma
- LSCC:
-
Laryngeal squamous cell carcinoma
- TSCC:
-
Tongue squamous cell carcinoma
- OPSCC:
-
Oropharyngeal squamous cell carcinoma
- HPV:
-
Human papillomavirus
- TGF-β:
-
Transforming growth factor-β
- TGFβRII:
-
Transforming growth factor- β type II receptor
- IL:
-
Interleukin
- TNF‐α:
-
Tumor necrosis factor‐α
- VEGF:
-
Vascular endothelial growth factor
- PDGF:
-
Platelet-derived growth factor
- MIF:
-
Macrophage migration inhibitory factor
- IFN:
-
Interferon
- NF-κB:
-
Nuclear factor-k-gene binding
- STAT:
-
Signal transducer and activator of transcription
- MAPK:
-
Mitogen-activated protein kinase
- PI3K:
-
Phosphatidylinositol 3-kinase
- ncRNAs:
-
Non-coding RNAs
- lncRNAs:
-
Long non-coding RNAs
- miRNAs:
-
MicroRNAs
- circRNAs:
-
Circular RNAs
- EMT:
-
Epithelial to mesenchymal transition
- TME:
-
Tumor microenvironment
- CAF:
-
Cancer-associated fibroblasts
- CSC:
-
Cancer stem cells
References
Johnson DE, Burtness B, Leemans CR et al (2020) Head and neck squamous cell carcinoma. Nat Rev Dis Primer 6:1–22. https://doi.org/10.1038/s41572-020-00224-3
Canning M, Guo G, Yu M et al (2019) heterogeneity of the head and neck squamous cell carcinoma immune landscape and its impact on immunotherapy. Front Cell Dev Biol. https://doi.org/10.3389/fcell.2019.00052
Zhang L, Meng X, Zhu X et al (2019) Long non-coding RNAs in oral squamous cell carcinoma: biologic function, mechanisms and clinical implications. Mol Cancer 18:102. https://doi.org/10.1186/s12943-019-1021-3
Muzaffar J, Bari S, Kirtane K, Chung CH (2021) Recent advances and future directions in clinical management of head and neck squamous cell carcinoma. Cancers 13:338. https://doi.org/10.3390/cancers13020338
Fialová A, Koucký V, Hajdušková M et al (2020) Immunological network in head and neck squamous cell carcinoma—a prognostic tool beyond HPV status. Front Oncol 10:1701. https://doi.org/10.3389/fonc.2020.01701
Koucký V, Hladíková K, Táborská E et al (2021) The cytokine milieu compromises functional capacity of tumor-infiltrating plasmacytoid dendritic cells in HPV-negative but not in HPV-positive HNSCC. Cancer Immunol Immunother 70:2545–2557. https://doi.org/10.1007/s00262-021-02874-y
Dong H, Shu X, Xu Q et al (2021) Current status of human papillomavirus-related head and neck cancer: from viral genome to patient care. Virol Sin 36:1284–1302. https://doi.org/10.1007/s12250-021-00413-8
Leemans CR, Snijders PJF, Brakenhoff RH (2018) The molecular landscape of head and neck cancer. Nat Rev Cancer 18:269–282. https://doi.org/10.1038/nrc.2018.11
Alsahafi E, Begg K, Amelio I et al (2019) Clinical update on head and neck cancer: molecular biology and ongoing challenges. Cell Death Dis 10:1–17. https://doi.org/10.1038/s41419-019-1769-9
Nisar S, Yousuf P, Masoodi T et al (2021) Chemokine-cytokine networks in the head and neck tumor microenvironment. Int J Mol Sci 22:4584. https://doi.org/10.3390/ijms22094584
Griffith JW, Sokol CL, Luster AD (2014) Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev Immunol 32:659–702. https://doi.org/10.1146/annurev-immunol-032713-120145
Borish LC, Steinke JW (2003) 2. Cytokines and chemokines. J Allergy Clin Immunol 111:S460–S475. https://doi.org/10.1067/mai.2003.108
Ralli M, Grasso M, Gilardi A et al (2020) The role of cytokines in head and neck squamous cell carcinoma: a review. Clin Ter 171(2):e7–e93
Partlová S, Bouček J, Kloudová K et al (2015) Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma. Oncoimmunology 4:e965570. https://doi.org/10.4161/21624011.2014.965570
Kindt N, Descamps G, Lechien JR et al (2019) Involvement of HPV infection in the release of macrophage migration inhibitory factor in head and neck squamous cell carcinoma. J Clin Med 8:75. https://doi.org/10.3390/jcm8010075
Mytilineos D, Ezić J, von Witzleben A et al (2020) Peripheral cytokine levels differ by HPV status and change treatment-dependently in patients with head and neck squamous cell carcinoma. Int J Mol Sci 21:5990. https://doi.org/10.3390/ijms21175990
Bedi A, Chang X, Noonan K et al (2012) Inhibition of TGF-β enhances the in vivo antitumor efficacy of EGF receptor-targeted therapy. Mol Cancer Ther 11:2429–2439. https://doi.org/10.1158/1535-7163.MCT-12-0101-T
Jo S, Juhasz A, Zhang K et al (2009) Human papillomavirus infection as a prognostic factor in oropharyngeal squamous cell carcinomas treated in a prospective phase II clinical trial. Anticancer Res 29(5):1467–1474
Troy JD, Weissfeld JL, Youk AO et al (2013) Expression of EGFR, VEGF, and NOTCH1 suggest differences in tumor angiogenesis in HPV-positive and HPV-negative head and neck squamous cell carcinoma. Head Neck Pathol 7:344–355. https://doi.org/10.1007/s12105-013-0447-y
Baruah P, Lee M, Wilson POG et al (2015) Impact of p16 status on pro- and anti-angiogenesis factors in head and neck cancers. Br J Cancer 113:653–659. https://doi.org/10.1038/bjc.2015.251
Pang X, Tang Y-L, Liang X-H (2018) Transforming growth factor-β signaling in head and neck squamous cell carcinoma: insights into cellular responses. Oncol Lett 16:4799–4806. https://doi.org/10.3892/ol.2018.9319
Wang X, Lin Y (2008) Tumor necrosis factor and cancer, buddies or foes? Acta Pharmacol Sin 29:1275–1288. https://doi.org/10.1111/j.1745-7254.2008.00889.x
Platanias LC (2005) Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 5:375–386. https://doi.org/10.1038/nri1604
Briukhovetska D, Dörr J, Endres S et al (2021) Interleukins in cancer: from biology to therapy. Nat Rev Cancer 21:481–499. https://doi.org/10.1038/s41568-021-00363-z
Jebreel A, Mistry D, Loke D et al (2007) Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer. J Laryngol Otol 121:246–252. https://doi.org/10.1017/S0022215106002428
Tong M, Lloyd B, Pei P, Mallery SR (2008) Human head and neck squamous cell carcinoma cells are both targets and effectors for the angiogenic cytokine, VEGF. J Cell Biochem 105:1202–1210. https://doi.org/10.1002/jcb.21920
Lin L-H, Lin J-S, Yang C-C et al (2020) Overexpression of platelet-derived growth factor and its receptor are correlated with oral tumorigenesis and poor prognosis in oral squamous cell carcinoma. Int J Mol Sci 21:2360. https://doi.org/10.3390/ijms21072360
Wang S, Cen X, Liang X, Tang Y (2016) Macrophage migration inhibitory factor: a potential driver and biomarker for head and neck squamous cell carcinoma. Oncotarget 8:10650–10661. https://doi.org/10.18632/oncotarget.12890
Landscape of transcription in human cells | Nature. https://www.nature.com/articles/nature11233. Accessed 24 Jul 2021
Statello L, Guo C-J, Chen L-L, Huarte M (2021) Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol 22:96–118. https://doi.org/10.1038/s41580-020-00315-9
Tripathi S, Shree B, Mohapatra S et al (2021) The expanding regulatory mechanisms and cellular functions of long non-coding RNAs (lncRNAs) in neuroinflammation. Mol Neurobiol 58:2916–2939. https://doi.org/10.1007/s12035-020-02268-8
Bartel DP (2018) Metazoan microRNAs. Cell 173:20–51. https://doi.org/10.1016/j.cell.2018.03.006
Czech B, Munafò M, Ciabrelli F et al (2018) piRNA-guided genome defense: from biogenesis to silencing. Annu Rev Genet 52:131–157. https://doi.org/10.1146/annurev-genet-120417-031441
Salmena L, Poliseno L, Tay Y et al (2011) A ceRNA hypothesis: the Rosetta stone of a hidden RNA language? Cell 146:353–358. https://doi.org/10.1016/j.cell.2011.07.014
Rinn JL, Chang HY (2020) Long noncoding RNAs: molecular modalities to organismal functions. Annu Rev Biochem 89:283–308. https://doi.org/10.1146/annurev-biochem-062917-012708
Kristensen LS, Andersen MS, Stagsted LVW et al (2019) The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet 20:675–691. https://doi.org/10.1038/s41576-019-0158-7
Cheng D, Wang J, Dong Z, Li X (2021) Cancer-related circular RNA: diverse biological functions. Cancer Cell Int 21:11. https://doi.org/10.1186/s12935-020-01703-z
Noncoding RNAs in Cancer Development | Annual Review of Cancer Biology. https://www.annualreviews.org/doi/abs/10.1146/annurev-cancerbio-050216-034443. Accessed 28 Jul 2021
Momen-Heravi F, Bala S (2018) Emerging role of non-coding RNA in oral cancer. Cell Signal 42:134–143. https://doi.org/10.1016/j.cellsig.2017.10.009
Curry JM, Sprandio J, Cognetti D et al (2014) Tumor microenvironment in head and neck squamous cell carcinoma. Semin Oncol 41:217–234. https://doi.org/10.1053/j.seminoncol.2014.03.003
Douglas WG, Tracy E, Tan D et al (2004) Development of head and neck squamous cell carcinoma is associated with altered cytokine responsiveness. Mol Cancer Res MCR 2:585–593
Rapidis AD, Wolf GT (2009) Immunotherapy of head and neck cancer: current and future considerations. J Oncol 2009:346345. https://doi.org/10.1155/2009/346345
Berraondo P, Sanmamed MF, Ochoa MC et al (2019) Cytokines in clinical cancer immunotherapy. Br J Cancer 120:6–15. https://doi.org/10.1038/s41416-018-0328-y
Propper DJ, Balkwill FR (2022) Harnessing cytokines and chemokines for cancer therapy. Nat Rev Clin Oncol 19:237–253. https://doi.org/10.1038/s41571-021-00588-9
Liu L, Wang Q, Qiu Z et al (2020) Noncoding RNAs: the shot callers in tumor immune escape. Signal Transduct Target Ther 5:1–24. https://doi.org/10.1038/s41392-020-0194-y
Mollica Poeta V, Massara M, Capucetti A, Bonecchi R (2019) Chemokines and chemokine receptors: new targets for cancer immunotherapy. Front Immunol. https://doi.org/10.3389/fimmu.2019.00379
Arun G, Diermeier SD, Spector DL (2018) Therapeutic targeting of long non-coding RNAs in cancer. Trends Mol Med 24:257–277. https://doi.org/10.1016/j.molmed.2018.01.001
Carpenter S, Fitzgerald KA (2018) Cytokines and long noncoding RNAs. Cold Spring Harb Perspect Biol 10:a028589. https://doi.org/10.1101/cshperspect.a028589
Papoutsoglou P, Moustakas A (2020) Long non-coding RNAs and TGF-β signaling in cancer. Cancer Sci 111:2672–2681. https://doi.org/10.1111/cas.14509
Jiang M-C, Ni J-J, Cui W-Y et al (2019) Emerging roles of lncRNA in cancer and therapeutic opportunities. Am J Cancer Res 9:1354–1366
Li M, Ding X, Zhang Y et al (2020) Antisense oligonucleotides targeting lncRNA AC104041.1 induces antitumor activity through Wnt2B/β-catenin pathway in head and neck squamous cell carcinomas. Cell Death Dis 11:1–12. https://doi.org/10.1038/s41419-020-02820-3
TGF-? regulates the ERK/MAPK pathway independent of the SMAD pathway by repressing miRNA-124 to increase MALAT1 expression in nasopharyngeal carcinoma - PubMed. https://pubmed.ncbi.nlm.nih.gov/29710466/. Accessed 9 Dec 2021
Zhang T-H, Liang L-Z, Liu X-L et al (2019) LncRNA UCA1/miR-124 axis modulates TGFβ1-induced epithelial-mesenchymal transition and invasion of tongue cancer cells through JAG1/Notch signaling. J Cell Biochem 120:10495–10504. https://doi.org/10.1002/jcb.28334
Yokoyama S, Shigeishi H, Murodumi H et al (2021) TGF-β1 induces amoeboid-to-mesenchymal transition of CD44high oral squamous cell carcinoma cells via miR-422a downregulation through ERK activation and Cofilin-1 phosphorylation. J Oral Pathol Med 50:155–164. https://doi.org/10.1111/jop.13113
Lin Z, Sun L, Chen W et al (2014) miR-639 regulates transforming growth factor beta-induced epithelial–mesenchymal transition in human tongue cancer cells by targeting FOXC1. Cancer Sci 105:1288–1298. https://doi.org/10.1111/cas.12499
Cheng C-M, Shiah S-G, Huang C-C et al (2016) Up-regulation of miR-455-5p by the TGF-β–SMAD signalling axis promotes the proliferation of oral squamous cancer cells by targeting UBE2B. J Pathol 240:38–49. https://doi.org/10.1002/path.4752
You X, Zhou Z, Chen W et al (2020) MicroRNA-495 confers inhibitory effects on cancer stem cells in oral squamous cell carcinoma through the HOXC6-mediated TGF-β signaling pathway. Stem Cell Res Ther. https://doi.org/10.1186/s13287-020-1576-3
Chen L, Sun D-Z, Fu Y-G et al (2020) Upregulation of microRNA-141 suppresses epithelial-mesenchymal transition and lymph node metastasis in laryngeal cancer through HOXC6-dependent TGF-β signaling pathway. Cell Signal 66:109444. https://doi.org/10.1016/j.cellsig.2019.109444
Wang Y, Jiang Y, Chen L (2020) Role of miR-218-GREM1 axis in epithelial-mesenchymal transition of oral squamous cell carcinoma: an in vivo and vitro study based on microarray data. J Cell Mol Med 24:13824–13836. https://doi.org/10.1111/jcmm.15972
Chu T-H, Yang C-C, Liu C-J et al (2013) MiR-211 promotes the progression of head and neck carcinomas by targeting TGFβRII. Cancer Lett. https://doi.org/10.1016/j.canlet.2013.05.032
Wang Y, Wu C, Zhang C et al (2018) TGF-β-induced STAT3 overexpression promotes human head and neck squamous cell carcinoma invasion and metastasis through malat1/miR-30a interactions. Cancer Lett 436:52–62. https://doi.org/10.1016/j.canlet.2018.08.009
Cui W, Meng W, Zhao L et al (2019) TGF-β-induced long non-coding RNA MIR155HG promotes the progression and EMT of laryngeal squamous cell carcinoma by regulating the miR-155-5p/SOX10 axis. Int J Oncol 54:2005–2018. https://doi.org/10.3892/ijo.2019.4784
Shen H, Sun B, Yang Y et al (2020) MIR4435-2HG regulates cancer cell behaviors in oral squamous cell carcinoma cell growth by upregulating TGF-β1. Odontology 108:553–559. https://doi.org/10.1007/s10266-020-00488-x
Huang T, Huang W, Lu H et al (2018) Identification and validation a TGF-β-associated long non-coding RNA of head and neck squamous cell carcinoma by bioinformatics method. J Transl Med 16:46. https://doi.org/10.1186/s12967-018-1418-6
Zhang P, Liu Y, Li C et al (2019) LncRNA PAPAS promotes oral squamous cell carcinoma by upregulating transforming growth factor-β1. J Cell Biochem 120:16120–16127. https://doi.org/10.1002/jcb.28893
Liang K, Yang Y, Zha D et al (2019) Overexpression of lncRNA snaR is correlated with progression and predicts poor survival of laryngeal squamous cell carcinoma. J Cell Biochem 120:8492–8498. https://doi.org/10.1002/jcb.28136
Zhou B, Zhou Y, Liu Y et al (2021) Association of CASC18/miR-20a-3p/TGFB2 ceRNA axis with occult lymph node metastasis in tongue squamous cell carcinoma. Mol Med 27:1–13. https://doi.org/10.1186/s10020-021-00345-9
Full article: Regulation of transforming growth factor-beta1 by circANKS1B/miR-515–5p affects the metastatic potential and cisplatin resistance in oral squamous cell carcinoma. https://www.tandfonline.com/doi/full/10.1080/21655979.2021.2005221. Accessed 9 Dec 2021
Andersson B-Å, Lewin F, Lundgren J et al (2014) Plasma tumor necrosis factor-α and C-reactive protein as biomarker for survival in head and neck squamous cell carcinoma. J Cancer Res Clin Oncol 140:515–519. https://doi.org/10.1007/s00432-014-1592-8
Ew H, Sg S, Hy P et al (2019) TNF-α-induced miR-450a mediates TMEM182 expression to promote oral squamous cell carcinoma motility. PLoS ONE. https://doi.org/10.1371/journal.pone.0213463
Hong HS, Akhavan J, Lee SH et al (2020) Proinflammatory cytokine TNFα promotes HPV-associated oral carcinogenesis by increasing cancer stemness. Int J Oral Sci 12:1–10. https://doi.org/10.1038/s41368-019-0069-7
Zheng Z, Luan X, Zha J et al (2017) TNF-α inhibits the migration of oral squamous cancer cells mediated by miR-765-EMP3-p66Shc axis. Cell Signal 34:102–109. https://doi.org/10.1016/j.cellsig.2017.03.009
Wang L, Wei Y, Yan Y et al (2018) CircDOCK1 suppresses cell apoptosis via inhibition of miR-196a-5p by targeting BIRC3 in OSCC. Oncol Rep 39:951–966. https://doi.org/10.3892/or.2017.6174
Ferrari E, Pezzi ME, Cassi D et al (2021) Salivary cytokines as biomarkers for oral squamous cell carcinoma: a systematic review. Int J Mol Sci 22:6795. https://doi.org/10.3390/ijms22136795
Interleukin-17A promotes tongue squamous cell carcinoma metastasis through activating miR-23b/versican pathway | Oncotarget. https://www.oncotarget.com/article/14255/text/. Accessed 23 Jul 2021
Yu C-C, Tsai L-L, Wang M-L et al (2013) miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6–mediated paracrine effects in head and neck cancer. Cancer Res 73:3425–3440. https://doi.org/10.1158/0008-5472.CAN-12-3840
Zhou X, Ren Y, Liu A et al (2014) STAT3 inhibitor WP1066 attenuates miRNA-21 to suppress human oral squamous cell carcinoma growth in vitro and in vivo. Oncol Rep 31:2173–2180. https://doi.org/10.3892/or.2014.3114
Zhang X, Yang J, Bian Z et al (2019) Long noncoding RNA DANCR promotes nasopharyngeal carcinoma progression by interacting with STAT3, enhancing IL-6/JAK1/STAT3 signaling. Biomed Pharmacother 113:108713. https://doi.org/10.1016/j.biopha.2019.108713
Kong Y-G, Cui M, Chen S-M et al (2018) LncRNA-LINC00460 facilitates nasopharyngeal carcinoma tumorigenesis through sponging miR-149-5p to up-regulate IL6. Gene 639:77–84. https://doi.org/10.1016/j.gene.2017.10.006
Ding L, Ren J, Zhang D et al (2018) A novel stromal lncRNA signature reprograms fibroblasts to promote the growth of oral squamous cell carcinoma via LncRNA-CAF/interleukin-33. Carcinogenesis 39:397–406. https://doi.org/10.1093/carcin/bgy006
Puram SV, Tirosh I, Parikh AS et al (2017) Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer. Cell 171:1611-1624.e24. https://doi.org/10.1016/j.cell.2017.10.044
Chen S-F, Nieh S, Jao S-W et al (2013) The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma. J Pathol 231:180–189. https://doi.org/10.1002/path.4226
Lin Y-C, Huang W-Y, Lee T-Y et al (2021) Interleukin-33-enhanced CXCR4 signaling circuit mediated by carcinoma-associated fibroblasts promotes invasiveness of head and neck cancer. Cancers 13:3442. https://doi.org/10.3390/cancers13143442
Wang X, Wang C, Xu H, Xie H (2020) <p>Long non-coding RNA SLC25A21-AS1 promotes multidrug resistance in nasopharyngeal carcinoma by regulating miR-324-3p/IL-6 axis</p>. Cancer Manag Res 12:3949–3957. https://doi.org/10.2147/CMAR.S251820
Wolff HA, Rolke D, Rave-Fränk M et al (2011) Analysis of chemokine and chemokine receptor expression in squamous cell carcinoma of the head and neck (SCCHN) cell lines. Radiat Environ Biophys 50:145–154. https://doi.org/10.1007/s00411-010-0341-x
Kong F, He S, Shen X et al (2020) Integrated analysis of different mRNA and miRNA profiles in human hypopharyngeal squamous cell carcinoma sensitive and resistant to chemotherapy. Neoplasma 67:473–483. https://doi.org/10.4149/neo_2020_190320N249
Peng C-Y, Wang T-Y, Lee S-S et al (2018) Let-7c restores radiosensitivity and chemosensitivity and impairs stemness in oral cancer cells through inhibiting interleukin-8. J Oral Pathol Med 47:590–597. https://doi.org/10.1111/jop.12711
Li X, Fan Q, Li J et al (2017) MiR-124 down-regulation is critical for cancer associated fibroblasts-enhanced tumor growth of oral carcinoma. Exp Cell Res 351:100–108. https://doi.org/10.1016/j.yexcr.2017.01.001
Peng H-Y, Jiang S-S, Hsiao J-R et al (2016) IL-8 induces miR-424-5p expression and modulates SOCS2/STAT5 signaling pathway in oral squamous cell carcinoma. Mol Oncol 10:895–909. https://doi.org/10.1016/j.molonc.2016.03.001
Qu J-Q, Yi H-M, Ye X et al (2015) MiR-23a sensitizes nasopharyngeal carcinoma to irradiation by targeting IL-8/Stat3 pathway. Oncotarget 6:28341–28356. https://doi.org/10.18632/oncotarget.5117
MiRNA-203 reduces nasopharyngeal carcinoma radioresistance by targeting IL8/AKT signaling | Molecular Cancer Therapeutics. https://mct.aacrjournals.org/content/14/11/2653.long. Accessed 23 Jul 2021
Xu Y-X, Sun J, Xiao W-L, et al (2019) MiR-4513 mediates the proliferation and apoptosis of oral squamous cell carcinoma cells via targeting CXCL17. Eur Rev Med Pharmacol Sci 23:3821–3828. https://doi.org/10.26355/eurrev_201905_17809
Yang C-N, Deng Y-T, Tang J-Y et al (2015) MicroRNA-29b regulates migration in oral squamous cell carcinoma and its clinical significance. Oral Oncol 51:170–177. https://doi.org/10.1016/j.oraloncology.2014.10.017
Jiang X, Liu J, Li S et al (2020) CCL18-induced LINC00319 promotes proliferation and metastasis in oral squamous cell carcinoma via the miR-199a-5p/FZD4 axis. Cell Death Dis 11:1–13. https://doi.org/10.1038/s41419-020-02978-w
Wei H, Liu D, Sun J et al (2019) Circular RNA circ_0008450 upregulates CXCL9 expression by targeting miR-577 to regulate cell proliferation and invasion in nasopharyngeal carcinoma. Exp Mol Pathol 110:104288. https://doi.org/10.1016/j.yexmp.2019.104288
Wu H, Pang P, Liu M-D et al (2018) Upregulated miR-20a-5p expression promotes proliferation and invasion of head and neck squamous cell carcinoma cells by targeting of TNFRSF21. Oncol Rep 40:1138–1146. https://doi.org/10.3892/or.2018.6477
Liu M-D, Wu H, Wang S et al (2018) MiR-1275 promotes cell migration, invasion and proliferation in squamous cell carcinoma of head and neck via up-regulating IGF-1R and CCR7. Gene 646:1–7. https://doi.org/10.1016/j.gene.2017.12.049
Hui Y, Li Y, Jing Y, et al (2016) miRNA-101 acts as a tumor suppressor in oral squamous cell carcinoma by targeting CX chemokine receptor 7. Am J Transl Res 8:4902–4911
Yu T, Liu K, Wu Y et al (2014) MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/β-catenin signaling pathway. Oncogene 33:5017–5027. https://doi.org/10.1038/onc.2013.448
Luo H-N, Wang Z-H, Sheng Y et al (2013) miR-139 targets CXCR4 and inhibits the proliferation and metastasis of laryngeal squamous carcinoma cells. Med Oncol 31:789. https://doi.org/10.1007/s12032-013-0789-z
Zhang K, Zhou H, Yan B, Cao X (2020) TUG1/miR-133b/CXCR4 axis regulates cisplatin resistance in human tongue squamous cell carcinoma. Cancer Cell Int 20:148. https://doi.org/10.1186/s12935-020-01224-9
Zhao J, Li X-D, Wang M et al (2021) Circular RNA ABCB10 contributes to laryngeal squamous cell carcinoma (LSCC) progression by modulating the miR-588/CXCR4 axis. Aging 13:14078–14087. https://doi.org/10.18632/aging.203025
Shibuya M (2013) Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases. J Biochem (Tokyo) 153:13–19. https://doi.org/10.1093/jb/mvs136
Chen J, Lu F, Hu C (2019) MicroRNA-299 targets VEGFA and inhibits the growth, chemosensitivity and invasion of human nasopharyngeal carcinoma cells. J BUON 24:2049–2055
Sasahira T, Kurihara M, Bhawal UK et al (2012) Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer. Br J Cancer 107:700–706. https://doi.org/10.1038/bjc.2012.330
Shi Q, Dai J, Huang L (2019) microRNA-29a functions as a tumor suppressor in nasopharyngeal carcinoma 5–8F cells through targeting VEGF. Iran J Basic Med Sci 22:541–546. https://doi.org/10.22038/ijbms.2019.33818.8049
Zhang T, Liu M, Wang C et al (2011) Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression. Anticancer Res 31:3859–3863
Hung P-S, Tu H-F, Kao S-Y et al (2014) miR-31 is upregulated in oral premalignant epithelium and contributes to the immortalization of normal oral keratinocytes. Carcinogenesis 35:1162–1171. https://doi.org/10.1093/carcin/bgu024
Kumar B, Yadav A, Lang J et al (2012) Dysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis. PLoS ONE 7:e37601. https://doi.org/10.1371/journal.pone.0037601
Fu W, Lu Y, Hu B et al (2015) Long noncoding RNA Hotair mediated angiogenesis in nasopharyngeal carcinoma by direct and indirect signaling pathways. Oncotarget 7:4712–4723. https://doi.org/10.18632/oncotarget.6731
Zhang C-Z (2017) Long intergenic non-coding RNA 668 regulates VEGFA signaling through inhibition of miR-297 in oral squamous cell carcinoma. Biochem Biophys Res Commun 489:404–412. https://doi.org/10.1016/j.bbrc.2017.05.155
He K, Zhu Z-B, Shu R, Hong A (2020) LncRNA NEAT1 mediates progression of oral squamous cell carcinoma via VEGF-A and Notch signaling pathway. World J Surg Oncol 18:261. https://doi.org/10.1186/s12957-020-02028-x
Lu H, Kang F (2020) Down-regulating NEAT1 inhibited the viability and vasculogenic mimicry formation of sinonasal squamous cell carcinoma cells via miR-195-5p/VEGFA axis. Biosci Rep. https://doi.org/10.1042/BSR20201373
Cao Z-H, Cheng J-L, Zhang Y et al (2017) MicroRNA-375 inhibits oral squamous cell carcinoma cell migration and invasion by targeting platelet-derived growth factor-A. Mol Med Rep 15:922–928. https://doi.org/10.3892/mmr.2016.6057
Chen L, Zhou H, Guan Z (2019) CircRNA_000543 knockdown sensitizes nasopharyngeal carcinoma to irradiation by targeting miR-9/platelet-derived growth factor receptor B axis. Biochem Biophys Res Commun 512:786–792. https://doi.org/10.1016/j.bbrc.2019.03.126
Liu N, Jiang N, Guo R et al (2013) MiR-451 inhibits cell growth and invasion by targeting MIF and is associated with survival in nasopharyngeal carcinoma. Mol Cancer 12:123. https://doi.org/10.1186/1476-4598-12-123
Ma H, Chang H, Yang W et al (2020) A novel IFNα-induced long noncoding RNA negatively regulates immunosuppression by interrupting H3K27 acetylation in head and neck squamous cell carcinoma. Mol Cancer. https://doi.org/10.1186/s12943-019-1123-y
Thierauf J, Veit JA, Hess J (2017) Epithelial-to-mesenchymal transition in the pathogenesis and therapy of head and neck cancer. Cancers 9:76. https://doi.org/10.3390/cancers9070076
Wang Y, Wang S, Ren Y, Zhou X (2020) The role of lncRNA crosstalk in leading cancer metastasis of head and neck squamous cell carcinoma. Front Oncol 10:561833. https://doi.org/10.3389/fonc.2020.561833
Suarez-Carmona M, Lesage J, Cataldo D, Gilles C (2017) EMT and inflammation: inseparable actors of cancer progression. Mol Oncol 11:805–823. https://doi.org/10.1002/1878-0261.12095
Lin C-W, Lin P-Y, Yang P-C (2016) Noncoding RNAs in tumor epithelial-to-mesenchymal transition. Stem Cells Int 2016:e2732705. https://doi.org/10.1155/2016/2732705
Funding
Oral cancer research in VS lab is supported by funding from OPERA and CHDR Grants from BITS Pilani-Hyderabad Campus and ICMR Grant Number 2021-10878. Swati is supported by the DST Inspire fellowship (Registration no. IF190343).
Author information
Authors and Affiliations
Contributions
VS conceived and designed the manuscript. S and VS wrote the manuscript. All authors have critically reviewed the manuscript and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
Not required.
Research involving human and/or animal participants
This article does not contain any studies with animal or human participants.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Swati, Sharma, V. The interplay of cytokine signaling and non-coding RNAs in head and neck squamous cell carcinoma pathobiology. Mol Biol Rep 49, 10825–10847 (2022). https://doi.org/10.1007/s11033-022-07770-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-022-07770-x